Compare ArcelorMittal SA (MT) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Sana Biotechnology Inc — how do they compare? ArcelorMittal SA trades at $75.17 (market cap $55.88B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: ArcelorMittal SA is far larger — about 49.5× Sana Biotechnology Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| MT | SANA | |
|---|---|---|
Market Cap | $55.88B | $1.13B |
Sector | Basic Materials | Health |
52-Week High | $75.35 | $5.92 |
52-Week Low | $32.44 | $2.68 |
Enterprise Value | $65.45B | $1.05B |
Dividend Yield | 0.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
